Ophthalmology · Pittsburgh, PA
NPI
1952360018
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
420 East North Avenue, Ste 116
Pittsburgh, PA, 15212
Phone (412) 359-6300
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
1,060 services
Medicare patients, 2024
229
Average age 72
Drug cost, 2024
$3.2M
206 prescriptions
Company payments, 2025
$20K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randall L Beatty was code 99213 (office e&m - established), 140 times for 117 patients. In total Randall L Beatty billed 1,060 services in 38 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 140 | 117 | $54.90 | $7,686 |
| 99214 Office E&M - Established | Office | 38 | 37 | $79.28 | $3,013 |
| 92083 Vision, Hearing, and Speech Services | Office | 31 | 27 | $38.70 | $1,200 |
| 99205 Office E&M - New | Office | 27 | 27 | $149.31 | $4,031 |
| 99204 Office E&M - New | Office | 23 | 23 | $111.24 | $2,558 |
| 99233 Hospital E&M - Subsequent | Facility | 19 | 19 | $89.49 | $1,700 |
| 92133 Computerized Ophthalmic Imaging | Office | 18 | 18 | $20.93 | $377 |
| 92081 Vision, Hearing, and Speech Services | Office | 17 | 17 | $20.61 | $350 |
| 92285 Standard X-ray | Office | 16 | 16 | $15.93 | $255 |
| 67800 Eye | Office | 11 | 11 | $87.33 | $961 |
By year: 2022 $69K for 2,588 services; 2023 $60K for 1,806 services; 2024 $40K for 1,060 services.
Medicare prescription drug claims, 2024
In 2024, the drug Randall L Beatty prescribed most often to Medicare patients was Tepezza (Teprotumumab-Trbw), with 49 prescriptions and refills. In total Randall L Beatty wrote 206 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tepezza Teprotumumab-Trbw | 49 | 49 | Under 11 | $3.2M |
| Erythromycin Erythromycin Base | 29 | 29 | 24 | $288 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 23 | 23 | 20 | $251 |
| Sodium Chloride 0.9 % Sodium Chloride | 22 | 22 | Under 11 | $77.94 |
| Cephalexin Generic | 13 | 13 | Under 11 | $43.53 |
Brand drugs: 95 claims; generic drugs: 111 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randall L Beatty $20K ($20K in general payments such as food, travel and fees) from 9 companies. The largest payer was Amgen Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 33 | $19K |
| Genentech USA, Inc. ROG.SW | 5 | $328 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $166 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $107 |
| Apellis Pharmaceuticals, Inc. APLS | 4 | $90.81 |
| Alcon Vision LLC ALC | 1 | $28.35 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $27.13 |
| Astellas Pharma US Inc 4503.T | 1 | $24.82 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $24.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.